-IBIS-1.7.0-
tx
digestive system
colon cancer
Nutrition

dietary guidelines

eating principles:

Alkaline Fasts under physician supervision 7-21 days

to protect against colon cancer, increase cellulose and hemicellulose (Fiber) food in diet

recommendations for all cancers:

seaweeds, mushrooms - Chinese black and Shiitake, figs, beets, beet tops, papaya, mung beans, licorice, sea cucumbers, carrot, garlic, walnut, lychee fruit, mulberries, asparagus, pumpkin, burdock, dandelion greens, white fungus, taro roots, pearl barley, grains, fresh fruits and vegetables (Ni, pp. 108-109)

therapeutic foods:

steamed carrots, squash, pumpkin; foods rich in Vitamin A (Shefi)

fresh juices:

carrot juice (Walker, p. 129)

liquid chlorophyll in water (Shefi)

carrot and spinach juice (Walker, p. 129)

specific remedies:

• soup of black or ling zhi mushrooms and white fungus, twice daily (Ni, p. 108)

boil together mung beans, pearl barley, adzuki beans, and figs (Ni, p. 108)

dandelion, burdock, and chrysanthemum flower tea (Ni, p. 109)

avoid:

• meat, chicken, coffee, cinnamon, anise, pepper, dairy products, spicy foods, high fat foods, smoking, constipation, stress

supplements

• Vitamin E 800 IU per day (Stahelin, 1984)

Calcium: 600 mg twice daily Calcium supplementation may help prevent colorectal cancer by reducing the formation of precancerous polyps. The presumed mechanism involves the ability of the calcium to bind to bile acids and thereby reduce irritation in the intestinal tract. Calcium carbonate at 600 mg twice daily was used in a four year study involving over 800 people at Dartmouth Medical School. (Lipkin, 1985; Baron JA, et al. N Engl J Med 1999 Jan 14;340(2):101-107.)

• Selenium 300 mcg per day

• Vitamin C 8-14 g per day(Pauling, 1976)

• acidophilus

• Vitamin A 200,000 IU per day (TOXIC DOSE)

• Shark cartilage 2 g per kg body wt q d (Lane, 1992)

• Maitake mushrooms: Research indicates that extracts from the fruiting body of Maitake showed antitumor action against allogenic and syngenic tumors by not only directly activating the various effector cells (macrophages, Natural Killer cells, cytotoxic T cells, etc.) to attack tumor cells, nut also by potentiating the activities of various mediators including lymphokines and IL-1 to enhance cellular immune functions and to prevent a decrease of immune functions in the tumor-bearing host (Nanba, H, et al. Chem Pharm Bull 1987,35:1162-1168; Yamada, Y, et al. Chemotherapy 1990;38:790-796; Nanba, H. J Naturopathic Med. 1(4):10-15)

» drug-related therapeutics:

• Vitamins C and E for patients using adriamycin: antioxidants, specifically reduces cardiac toxicity of adriamycin (Doxorubicin) (Fujita, et al., 1982, 42: p. 309-316; Ellison, 1985; 37 (3): 112-113; Am Heart J, 1986; 111: p. 95)

» drug interactions:

• Vitamins B1, B2, B3, Vitamin K and folic acid can become deficient in patients using chemotherapy due to consequent anorexia, damage to the digestive tract, and malabsorption (Dreizen, et al., 1990; 87 (1): 163-170)

• Vitamin K has been found to potentiate various chemotherapeutic drugs in animals (Taper, et al., 1987; 40: 575-579)

• Vitamin A and cancer chemotherapy, esp. fluorouracil (5-FU): vitamin A enhances antitumor effect in animals of fluorouracil (5-FU) (Nakagawa, et al., 1985; 76: 887-894)

Iron, B-12, Fat, Protein, Sodium, Calcium, Cholesterol, Carotene and neomycin (Mycifradin, Neobiotic): This broad spectrum antibiotic, used post-bowel surgery, induces damage to intestinal villi and precipitation of bile salts in the lumen lead to malabsorption of the above nutrients

footnotes

Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, Rothstein R, Summers RW, Snover DC, Beck GJ, Bond JH, Greenberg ER. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 1999 Jan 14;340(2):101-107.

Abstract: BACKGROUND AND METHODS: Laboratory, clinical, and epidemiologic evidence suggests that calcium may help prevent colorectal adenomas. We conducted a randomized, double-blind trial of the effect of supplementation with calcium carbonate on the recurrence of colorectal adenomas. We randomly assigned 930 subjects (mean age, 61 years; 72 percent men) with a recent history of colorectal adenomas to receive either calcium carbonate (3 g [1200 mg of elemental calcium] daily) or placebo, with follow-up colonoscopies one and four years after the qualifying examination. The primary end point was the proportion of subjects in whom at least one adenoma was detected after the first follow-up endoscopy but up to (and including) the second follow-up examination. Risk ratios for the recurrence of adenomas were adjusted for age, sex, lifetime number of adenomas before the study, clinical center, and length of the surveillance period. RESULTS: The subjects in the calcium group had a lower risk of recurrent adenomas. Among the 913 subjects who underwent at least one study colonoscopy, the adjusted risk ratio for any recurrence of adenoma with calcium as compared with placebo was 0.85 (95 percent confidence interval, 0.74 to 0.98; P=0.03). The main analysis was based on the 832 subjects (409 in the calcium group and 423 in the placebo group) who completed both follow-up examinations. At least one adenoma was diagnosed between the first and second follow-up endoscopies in 127 subjects in the calcium group (31 percent) and 159 subjects in the placebo group (38 percent); the adjusted risk ratio was 0.81 (95 percent confidence interval, 0.67 to 0.99; P=0.04). The adjusted ratio of the average number of adenomas in the calcium group to that in the placebo group was 0.76 (95 percent confidence interval, 0.60 to 0.96; P=0.02). The effect of calcium was independent of initial dietary fat and calcium intake. CONCLUSIONS: Calcium supplementation is associated with a significant - though moderate - reduction in the risk of recurrent colorectal adenomas.

Nanba, H. Activity of Maitake D-fraction to Inhibit Carcinogenisis and Metastasis. Annals of the New York Academy of Sciences. September 30, 1995:243-245.

Nanba, H, Antitumor activity of orally administered D-fraction from Maitake mushroom (Grifola frondosa). J Naturopathic Med. 1(4):10-15.

Nanba, H, Hamaguchi, A, Kuroda, H. The chemical structure of an antitumor polysaccharide in fruit bodies of Grifola frondosa (maitake). Chem Pharm Bull 1987,35:1162-1168.

Nanba, H. Immunostimulant activity in in-vivo and anti-HIV activity in vitro of 3 branched b-1-6-glucans extracted from maitake mushrooms (Grifola frondosa). Abstract, VIII International Conference on AIDS, 1992.

Yamada, Y, Nanba, H, Kuroda, H. Antitumor effect of orally administered extracts from fruit body of Grifola frondosa (maitake). Chemotherapy 1990;38:790-796.

See also Sources file